Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Publikation

Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Wissenschaftlicher Artikel/Review - 06.09.2017

Seiffge David Julian, Traenka Christopher, Polymeris Alexandros A, Thilemann Sebastian, Wagner Benjamin, Hert Lisa, Delignette-Muller Marie Laure, Gensicke Henrik, Peters Nils, Nickel Christian H, Stippich Christoph, Sutter Raoul, Marsch Stephan C, Fisch Urs, Guzman Raphael, De Marchis Gian Marco, Lyrer Philippe A, Bonati Leo H, Tsakiris Dimitrios A, Engelter Stefan T

Zitation

Seiffge D, Traenka C, Polymeris A, Thilemann S, Wagner B, Hert L, Delignette-Muller M, Gensicke H, Peters N, Nickel C, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis G, Lyrer P, Bonati L, Tsakiris D, Engelter S. Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice. J Stroke 2017; 19:347-355.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Stroke 2017; 19

Veröffentlichungsdatum

06.09.2017

ISSN (Druck)

2287-6391

Seiten

347-355

Kurzbeschreibung/Zielsetzung

Standard operating procedures (SOP) incorporating plasma levels of rivaroxaban might be helpful in selecting patients with acute ischemic stroke taking rivaroxaban suitable for IVthrombolysis (IVT) or endovascular treatment (EVT).